This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Drugs

Drugs


Company Last %CHNG Volume
Asterias Biotherapeutics Inc (AST) 4.6 24.32 1.6342 M
Advaxis Inc (ADXS) 20.33 17.79 2.745915 M
Epizyme Inc (EPZM) 24.0 17.24 0.952561 M
Juno Therapeutics Inc (JUNO) 53.33 15.18 15.675111 M
Juno Therapeutics Inc (JUNO) 53.33 15.18 15.675111 M
ARCA biopharma Inc (ABIO) 1.15 15.0 0.919859 M
Progenics Pharmaceuticals Inc (PGNX) 7.46 13.72 1.641192 M
Alder BioPharmaceuticals Inc (ALDR) 52.97 12.85 2.796554 M
Summit Therapeutics PLC (SMMT) 10.65 0.0 M
Summit Therapeutics PLC (SMMT) 10.65 0.0 M
Nivalis Therapeutics Inc (NVLS) 15.0 0.0 M
Nivalis Therapeutics Inc (NVLS) 15.0 0.0 M
Enzyme Bio Systems (ENZBD) 0.55 0.0 M
Enzyme Bio Systems (ENZBD) 0.55 0.0 M
Company Last %CHNG Volume
Pieris Pharmaceuticals Inc (PIRS) 2.75 -15.64 1.20323 M
Egalet Corp (EGLT) 14.43 -7.32 0.235802 M
Cyanotech Corp (CYAN) 9.47 -7.16 0.019837 M
Skystar Bio-Pharmaceutical Co (SKBI) 2.66 -6.67 0.039041 M
Biotie Therapies Corp (BITI) 19.97 -6.42 0.056998 M
Cleveland BioLabs Inc (CBLI) 4.34 -5.45 0.41554 M
Provectus Biopharmaceuticals Inc (PVCT) 0.54 -5.26 0.85659 M
Ampio Pharmaceuticals Inc (AMPE) 2.37 -5.2 0.87684 M
ProPhase Labs Inc (PRPH) 1.35 -4.92 0.008202 M
RXi Pharmaceuticals Corp (RXII) 0.49 -4.72 1.936886 M
Company Last %CHNG Volume
Pfizer Inc (PFE) 33.53 -0.18 34.216588 M
Pfizer Inc (PFE) 33.53 -0.18 34.216588 M
Juno Therapeutics Inc (JUNO) 53.33 15.18 15.675111 M
Juno Therapeutics Inc (JUNO) 53.33 15.18 15.675111 M
Merck & Co Inc (MRK) 56.93 -0.63 11.56799 M
Merck & Co Inc (MRK) 56.93 -0.63 11.56799 M
AbbVie Inc (ABBV) 67.19 0.01 11.512663 M
Gilead Sciences Inc (GILD) 117.08 1.41 11.180098 M
Gilead Sciences Inc (GILD) 117.08 1.41 11.180098 M
Johnson & Johnson (JNJ) 97.46 -0.23 8.883853 M
Johnson & Johnson (JNJ) 97.46 -0.23 8.883853 M
Bristol-Myers Squibb Company (BMY) 66.54 0.86 6.233633 M
Summit Therapeutics PLC (SMMT) 10.65 0.0 M
Summit Therapeutics PLC (SMMT) 10.65 0.0 M
Nivalis Therapeutics Inc (NVLS) 15.0 0.0 M
Nivalis Therapeutics Inc (NVLS) 15.0 0.0 M
Enzyme Bio Systems (ENZBD) 0.55 0.0 M
Enzyme Bio Systems (ENZBD) 0.55 0.0 M
Company Last %CHNG Mkt Cap
Johnson & Johnson (JNJ) 97.46 -0.23 $276.306238774 B
Johnson & Johnson (JNJ) 97.46 -0.23 $276.306238774 B
Novartis AG (NVS) 98.34 -0.19 $239.670735599 B
Pfizer Inc (PFE) 33.53 -0.18 $208.868164127 B
Pfizer Inc (PFE) 33.53 -0.18 $208.868164127 B
Gilead Sciences Inc (GILD) 117.08 1.41 $175.61791461 B
Gilead Sciences Inc (GILD) 117.08 1.41 $175.61791461 B
Merck & Co Inc (MRK) 56.93 -0.63 $165.247220099 B
Merck & Co Inc (MRK) 56.93 -0.63 $165.247220099 B
Novo Nordisk A/S (NVO) 54.76 0.13 $148.294 B
Sanofi (SNY) 49.53 -0.62 $136.897566093 B
Allergan PLC (AGN) 303.46 1.41 $120.323526011 B
Amgen Inc (AMGN) 153.52 1.27 $120.146345385 B
Allergan PLC (ACT) 303.46 1.41 $117.333097869 B

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs